Oversee all clinical functions and own the clinical lifecycle end-to-end, with an immediate focus on Clinical Operations.
Oversee and lead execution of multi-national industry-sponsored clinical trials in partnership with CROs, specialized vendors, and consultants.
Manage study design, site strategy, patient recruitment, and data quality to ensure regulatory and product performance goals are met.
Lead regulatory strategy and execution, including IDE and other submissions for future products.
Represent Motif directly with FDA and other regulatory bodies, including pre-submission meetings.
Directly manage clinical and regulatory personnel, including hiring, onboarding, training, and performance management.
Partner with cross-functional teams to ensure study design supports product development and market access strategy.
GCP
Showing 1 of 2 positions
Overview
Motif Neurotech develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses. The company's primary product is DOT, a miniature, wirelessly powered, implantable brain stimulator designed to treat treatment-resistant depression (TRD). The DOT device is intended for implantation in an outpatient procedure and works by stimulating the Central Executive Network. Patients receive therapy at home via a hat that pairs with the implant. Motif Neurotech received FDA approval in April 2026 to begin its first clinical trial (RESONATE Early Feasibility Study) for the DOT XCS System in patients with treatment-resistant depression. They have successfully conducted a first-in-human implantation of their neurostimulator. The company is exploring the use of DOT for bipolar disorder, OCD, Alzheimer's disease, and substance use disorder. Motif Neurotech is a for-profit company with 11-50 employees.
Culture
Motif Neurotech emphasizes an open, honest, and curious culture, valuing challenging conventional methods to find efficiencies. Their Houston office is located at the Texas Medical Center - Innovation (TMCi).
Technology
Motif Neurotech's technology stack consists of a small implant that is wirelessly powered via magnetic fields from an external wearable transmitter, configured and controlled from a programming interface. This system delivers stimulation therapy to cortical targets and is designed to record biomarkers. The company uses Common Crawl and CommonCrawl Top 5m technologies. They are completing the development of their first neural stimulation system and preparing for future versions with additional functionality based on their platform technology.
Working at Motif Neurotech
Motif Neurotech offers remote work options for some positions, such as the Director of Clinical Science and Applied Research role, which allows for remote work with occasional visits to the Houston headquarters (approximately 4-5 times per year). The company operates in Houston, Texas. Candidates for the Director of Clinical Science and Applied Research role need 10+ years of experience in clinical development within the medical device, pharmaceutical, or biotech industry, with leadership responsibility. Experience in active implantable medical devices, neuromodulation, or neurostimulation therapies is considered a bonus. An advanced degree (MD, PhD, or equivalent) and a record of peer-reviewed publications or successful grant applications are also considered a bonus. Visa sponsorship is not offered for this role. The company has 11-50 employees.
Benefits and Perks
For regular full-time, exempt, salaried US employees, Motif Neurotech offers a benefits package.
Medical, dental, and vision insurance for employees and their dependents